search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
28 Handheld FTIR Added to Portable Spectroscopy Portfolio in the UK


Analytik are delighted to announce a new arrangement to become sole value added resellers in the UK and Ireland for Agilent Technologies' portable and handheld FTIR spectrometers for routine analysis and field use. Analytik's strong position as specialists in portable spectroscopy will drive the continued establishment of out-of-lab applications for FTIR in markets such as petrochemical, chemical, environmental, forensic, art conservation, polymer, and geosciences. Agilent's unique, patented portable Fourier transform infrared (FTIR) analysers offer customers extraordinary analytical capabilities in a compact size, with performance levels directly comparable to benchtop systems.


This extends the proven capabilities of FTIR technology by rendering sample preparation obsolete and ensuring real time results. There are three models to choose from; all based on the specially designed, rugged interferometer, field-proven for the most challenging environments. For the out-of-lab analysis of composites, coatings, paints, polymers, liquids, solids, pastes and gels the 4100 ExoScan handheld FTIR is a rugged single module system featuring a choice of interchangeable sampling interfaces including diffuse reflectance, grazing angle, specular or ATR. The 4200 FlexScan handheld FTIR has the same high performance as the 4100 with a single dedicated sampling interface. The optical and electronics modules have been separated for maximum flexibility of repetitive measurements.


Finally, the Agilent 4500 Series portable FTIR compact spectrometer is packaged in a weather resistant housing making it ideal for outdoor use. Three versions of the 4500 Series are available including ATR for powders, pastes and gels, and fixed pathlength transmission and selectable pathlength for the most demanding quantitative liquids measurement. David Coe, Senior Director, EMEAI, Spectroscopy for Agilent Technologies says, "We are very pleased to welcome Analytik as a partner in the UK. Their specialist technical and application knowledge of the Mobile Measurement market, especially in the area of Hand Held, portable technologies helps extend the reach of Agilent's products to allow customers the ability to perform their analyses directly at the point of sample."


"Agilent's handheld and portable FTIR products are a great fit with Analytik" says Tom Greenwell, Marketing Manager at Analytik. "We already supply portable Near-Infrared (NIR) and Raman systems to the UK and Ireland, and now look forward to delivering the three core molecular spectroscopy techniques, NIR, Raman and FTIR, as portable solutions."


SPECTROSCOPY Circle no. 603


Do you


analyse,monitor ortestfor


Mercury?


28th July - 2nd August 2013, Edinburgh, Scotland Mercury as a Global Pollutant


The 11th International Conference on Mercury as a Global Pollutant returns after 10 years to Europe in 2013.


The event will attract over 1000 international delegates and will discuss scientific advances concerning mercury in the environment.


The 2013 meeting will be of particular importance as it coincides with the United Nations Environment Programme’s legally binding global treaty on Mercury.


Companies and individuals who are interested in presenting, attending or exhibiting should register their interest today.


www.mercury2013.com


BD Diagnostics, a segment of BD (Becton, Dickinson and Company), recently announced that it obtained CE Marking for the BD MAX™ MRSA Assay to rapidly and accurately identify methicillin- resistant Staphylococcus aureus (MRSA) in patients. Rapid and accurate information enables infection control measures to be implemented faster which can positively impact patient management.


“When we launched BD MAX earlier this year, our goal was to provide a next-generation molecular testing system designed to accommodate a broad range of assays that laboratories want and need,” said Tom Polen, President, BD Diagnostics – Diagnostic Systems.


“As the first healthcare-associated infection assay developed by BD for use on the BD MAX System, this milestone represents further confirmation of the potential of this fully-automated system. This system enables laboratories to offer a broad range of molecular tests that meet both their current and future clinical needs.”


BD MAX is the first and only fully automated, bench-top molecular system designed to perform a broad range of molecular testing. This offers laboratory professionals the flexibility and versatility to perform CE/in vitro diagnostic (IVD) assays and user defined protocols on the same platform.


The dual functionality of open system and CE/IVD capabilities on the BD MAX System enables laboratories to consolidate a broad range of molecular tests on a single workstation. This flexibility provides clinicians with the best information to make critical treatment and management decisions to improve patient care.


+44 (0) 1727 858840 info@mercury2013.com


According to Polen, BD plans to build on the successful launch of the BD MAX MRSA Assay by developing additional assays for the BD MAX System for a broad range of disease categories. There are now more than 20 assays in the BD MAX System’s content-rich menu pipeline.


LAB PRODUCTS Circle no. 604


Healthcare-Associated Infection Assay Launches in Europe


LABMATE UK & IRELAND - APRIL 2012


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36